Butylated hydroxytoluene, lipid-enveloped viruses, and AIDS.
Butylated hydroxytoluene (BHT) is a potent inactivator of lipid-enveloped viruses. The viral envelope structure is physically disturbed by BHT, thereby interfering with viral adsorption to host cells. Since the virus responsible for AIDS (HTLV III) contains a lipid envelope, BHT warrants investigation as a potential antiviral agent against the AIDS virus.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000998:Antiviral Agents; D002084:Butylated Hydroxytoluene / Q000494:pharmacology*; D006678:HIV / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism; D008954:Models, Biological
D000998:Antiviral Agents; D002084:Butylated Hydroxytoluene